HUP9901438A3 - Therapeutic pyrimidine compounds - Google Patents
Therapeutic pyrimidine compoundsInfo
- Publication number
- HUP9901438A3 HUP9901438A3 HU9901438A HUP9901438A HUP9901438A3 HU P9901438 A3 HUP9901438 A3 HU P9901438A3 HU 9901438 A HU9901438 A HU 9901438A HU P9901438 A HUP9901438 A HU P9901438A HU P9901438 A3 HUP9901438 A3 HU P9901438A3
- Authority
- HU
- Hungary
- Prior art keywords
- therapeutic
- pyrimidine compounds
- pyrimidine
- compounds
- therapeutic pyrimidine
- Prior art date
Links
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Percussion Or Vibration Massage (AREA)
- Steroid Compounds (AREA)
- Pyrane Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9512868.2A GB9512868D0 (en) | 1995-06-23 | 1995-06-23 | Therapeutic compounds |
| GBGB9608372.0A GB9608372D0 (en) | 1996-04-23 | 1996-04-23 | Therapeutic compounds |
| GBGB9608547.7A GB9608547D0 (en) | 1996-04-25 | 1996-04-25 | Therapeutic compounds |
| US1676296P | 1996-05-03 | 1996-05-03 | |
| US1697396P | 1996-05-07 | 1996-05-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9901438A2 HUP9901438A2 (hu) | 1999-08-30 |
| HUP9901438A3 true HUP9901438A3 (en) | 2000-07-28 |
Family
ID=27517294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9901438A HUP9901438A3 (en) | 1995-06-23 | 1996-06-24 | Therapeutic pyrimidine compounds |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5945406A (hu) |
| EP (1) | EP0851866B1 (hu) |
| JP (1) | JPH11507942A (hu) |
| KR (1) | KR19990028344A (hu) |
| CN (1) | CN1196059A (hu) |
| AT (1) | ATE204878T1 (hu) |
| AU (1) | AU6234296A (hu) |
| CA (1) | CA2225247A1 (hu) |
| DE (1) | DE69614867T2 (hu) |
| ES (1) | ES2162078T3 (hu) |
| HU (1) | HUP9901438A3 (hu) |
| ID (1) | ID16479A (hu) |
| IL (1) | IL122700A0 (hu) |
| NO (1) | NO976043L (hu) |
| PL (1) | PL328266A1 (hu) |
| WO (1) | WO1997000882A1 (hu) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997000882A1 (en) * | 1995-06-23 | 1997-01-09 | Oxford Glycosciences (Uk) Limited | Therapeutic compounds |
| DE19741738A1 (de) * | 1997-09-22 | 1999-03-25 | Hoechst Ag | Linker-Nucleosid, seine Herstellung und Verwendung |
| DE19741715A1 (de) | 1997-09-22 | 1999-03-25 | Hoechst Ag | Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung |
| DE19837387A1 (de) | 1998-08-18 | 2000-02-24 | Aventis Res & Tech Gmbh & Co | 3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung |
| US6344460B1 (en) * | 1999-03-19 | 2002-02-05 | Lonza Inc. | Propynyl uracils |
| US20050143300A1 (en) * | 2003-10-10 | 2005-06-30 | Ma Jian-Xing | Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same |
| JP5677951B2 (ja) * | 2008-07-11 | 2015-02-25 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 抗癌活性を有する２−デオキシ単糖の新規なアセテート |
| WO2014165736A2 (en) | 2013-04-05 | 2014-10-09 | Board Of Regents, The University Of Texas System | Esters of 2-deoxy-monosaccharides with anti proliferative activity |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3354160A (en) * | 1965-07-22 | 1967-11-21 | Hoffmann La Roche | Tri-lower alkyl-silyl-5-fluoropyrimidines |
| DK149818C (da) * | 1976-10-28 | 1987-04-06 | Sankyo Co | Analogifremgangsmaade til fremstilling af 5-fluoruracil-derivater |
| US4248999A (en) * | 1976-10-28 | 1981-02-03 | Sankyo Company Limited | 5-Fluorouracil derivatives and process for preparing thereof |
| JPS55153796A (en) * | 1979-05-21 | 1980-11-29 | Meiji Seika Kaisha Ltd | 5-fluorouracil nucleoside and its preparation |
| JPS5829798A (ja) * | 1981-08-15 | 1983-02-22 | Tetsuo Suami | ヌクレオシド類似体 |
| JPS5872599A (ja) * | 1981-10-27 | 1983-04-30 | Kanto Ishi Pharma Co Ltd | 複合糖質誘導体 |
| EP0119650A3 (en) * | 1983-03-21 | 1987-09-30 | THE PROCTER & GAMBLE COMPANY | Galactosyl-insulin conjugates useful in treating diabetics |
| JP2696393B2 (ja) * | 1989-05-09 | 1998-01-14 | 株式会社日本抗体研究所 | チミン誘導体及びこれを含有する抗ｈｉｖ剤 |
| JPH0517494A (ja) * | 1991-07-10 | 1993-01-26 | Nippon Shoji Kk | グルコサミン誘導体 |
| ATE284894T1 (de) * | 1994-10-24 | 2005-01-15 | Genencor Int | L-pyranosyl-nukleoside |
| WO1997000882A1 (en) * | 1995-06-23 | 1997-01-09 | Oxford Glycosciences (Uk) Limited | Therapeutic compounds |
| GB9626450D0 (en) * | 1996-12-20 | 1997-02-05 | Oxford Glycosciences Uk Ltd | Therapeutic compounds |
-
1996
- 1996-06-24 WO PCT/GB1996/001519 patent/WO1997000882A1/en not_active Application Discontinuation
- 1996-06-24 ES ES96920967T patent/ES2162078T3/es not_active Expired - Lifetime
- 1996-06-24 EP EP96920967A patent/EP0851866B1/en not_active Expired - Lifetime
- 1996-06-24 DE DE69614867T patent/DE69614867T2/de not_active Expired - Fee Related
- 1996-06-24 AU AU62342/96A patent/AU6234296A/en not_active Abandoned
- 1996-06-24 ID IDP961794A patent/ID16479A/id unknown
- 1996-06-24 PL PL96328266A patent/PL328266A1/xx unknown
- 1996-06-24 KR KR1019970709659A patent/KR19990028344A/ko not_active Application Discontinuation
- 1996-06-24 IL IL12270096A patent/IL122700A0/xx unknown
- 1996-06-24 CA CA002225247A patent/CA2225247A1/en not_active Abandoned
- 1996-06-24 CN CN96196248A patent/CN1196059A/zh active Pending
- 1996-06-24 AT AT96920967T patent/ATE204878T1/de active
- 1996-06-24 HU HU9901438A patent/HUP9901438A3/hu unknown
- 1996-06-24 JP JP9503686A patent/JPH11507942A/ja not_active Ceased
-
1997
- 1997-12-22 NO NO976043A patent/NO976043L/no not_active Application Discontinuation
- 1997-12-23 US US08/997,309 patent/US5945406A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ID16479A (id) | 1997-10-02 |
| DE69614867T2 (de) | 2002-04-11 |
| KR19990028344A (ko) | 1999-04-15 |
| EP0851866A1 (en) | 1998-07-08 |
| WO1997000882A1 (en) | 1997-01-09 |
| US5945406A (en) | 1999-08-31 |
| CN1196059A (zh) | 1998-10-14 |
| EP0851866B1 (en) | 2001-08-29 |
| MX9710529A (es) | 1998-08-30 |
| JPH11507942A (ja) | 1999-07-13 |
| IL122700A0 (en) | 1998-12-06 |
| NO976043L (no) | 1998-02-20 |
| ES2162078T3 (es) | 2001-12-16 |
| HUP9901438A2 (hu) | 1999-08-30 |
| CA2225247A1 (en) | 1997-01-09 |
| AU6234296A (en) | 1997-01-22 |
| PL328266A1 (en) | 1999-01-18 |
| DE69614867D1 (de) | 2001-10-04 |
| ATE204878T1 (de) | 2001-09-15 |
| NO976043D0 (no) | 1997-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA983176B (en) | Therapeutic compounds | |
| IL131521A0 (en) | Pyrimidine derivatives | |
| GB9421709D0 (en) | Therapeutic compounds | |
| AP9600895A0 (en) | Therapeutic compounds | |
| GB9500691D0 (en) | Compounds | |
| GB9600143D0 (en) | Therapeutic compounds | |
| GB9506309D0 (en) | Pyrimidine compounds | |
| HUP9901438A3 (en) | Therapeutic pyrimidine compounds | |
| HU9503012D0 (en) | New pyrimidine derivatives | |
| GB9716345D0 (en) | Therapeutic compounds | |
| GB9716344D0 (en) | Therapeutic compounds | |
| GB9716347D0 (en) | Therapeutic compounds | |
| GB9626450D0 (en) | Therapeutic compounds | |
| GB2316077B (en) | Pyrimidine Compounds | |
| GB9515060D0 (en) | Therapeutic heterocyclic compounds | |
| GB9526110D0 (en) | Therapeutic compounds | |
| GB9523801D0 (en) | Therapeutic compounds | |
| GB9523558D0 (en) | Therapeutic compounds | |
| GB9512868D0 (en) | Therapeutic compounds | |
| GB9521463D0 (en) | Therapeutic heterocyclic compounds | |
| GB9515305D0 (en) | Therapeutic heterocyclic compounds | |
| GB9509419D0 (en) | Therapeutic heterocyclic compounds | |
| PL310059A1 (en) | Therapeutic oinment | |
| GB9705401D0 (en) | Therapeutic compounds | |
| GB9716111D0 (en) | Therapeutic compounds |